100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug

Pharmacol Rev. 1995 Jun;47(2):235-53.

Authors

P Popik¹, R T Layer, P Skolnick

Affiliation

¹ Laboratory of Neuroscience, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

PMID: 7568327

No abstract available

Publication types

Review

MeSH terms

Animals
Calcium / metabolism
Hallucinogens / chemistry
Hallucinogens / pharmacokinetics
Hallucinogens / pharmacology*
Hallucinogens / therapeutic use
Humans
Ibogaine / chemistry
Ibogaine / pharmacokinetics
Ibogaine / pharmacology*
Ibogaine / therapeutic use
Neurotoxins / adverse effects
Neurotoxins / toxicity
Receptors, GABA / drug effects
Receptors, GABA / metabolism
Receptors, Glutamate / drug effects
Receptors, Glutamate / metabolism
Receptors, Opioid / drug effects
Receptors, Opioid / metabolism
Serotonin / metabolism
Substance Withdrawal Syndrome / drug therapy*
Substance Withdrawal Syndrome / mortality
Substance-Related Disorders / drug therapy
Synaptic Transmission / drug effects*

Substances

Hallucinogens
Neurotoxins
Receptors, GABA
Receptors, Glutamate
Receptors, Opioid
Serotonin
Ibogaine
Calcium